Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer

References

• Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN : cancer incidence, mortality and prevalence worldwide cancerbase No.5, version 2.0. IARC Press, Lyon 2002; 2004
   Google Scholar
• Creasman WT. Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment. Semin Oncol 1997; 24((1 Suppl 1))S1
   PubMed Web of Science ®Google Scholar
• DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol. 1985; 151(8)1009–15
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Perez CA, Kuten A, Simpson JR, Garcia DM, Camel HM, et al. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys. 1992; 22(5)905–11
   PubMed Web of Science ®Google Scholar
• Meerwaldt JH, Hoekstra CJ, van Putten WL, Tjokrowardojo AJ, Koper PC. Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors. Int J Radiat Oncol Biol Phys. 1990; 18(2)299–304
   PubMed Web of Science ®Google Scholar
• Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991; 40(1)55–65
   PubMed Web of Science ®Google Scholar
• Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987; 60((8 Suppl))2035–41
   PubMed Web of Science ®Google Scholar
• Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000; 22(355(9213))1404–11
   Google Scholar
• Descamps P, Calais G, Moire C, Bertrand P, Castiel M, Le FO, et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol. 1997; 64(1)54–8
   PubMed Web of Science ®Google Scholar
• Kuten A, Grigsby PW, Perez CA, Fineberg B, Garcia DM, Simpson JR. Results of radiotherapy in recurrent endometrial carcinoma: a retrospective analysis of 51 patients. Int J Radiat Oncol Biol Phys. 1989; 17(1)29–34
   PubMed Web of Science ®Google Scholar
• Vavra N, Denison U, Kucera H, Barrada M, Kurz C, Salzer H, et al. Prognostic factors related to recurrent endometrial carcinoma following initial surgery. Acta Obstet Gynecol Scand. 1993; 72(3)205–9
   PubMed Web of Science ®Google Scholar
• Mariani A, Webb MJ, Keeney GL, Lesnick TG, Podratz KC. Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol. 2002; 87(3)274–80
   PubMed Web of Science ®Google Scholar
• Sartori E, Laface B, Gadducci A, Maggino T, Zola P, Landoni F, et al. Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study. Int J Gynecol Cancer. 2003; 13(4)458–65
   PubMed Web of Science ®Google Scholar
• Berek JS, Hacker NF. Pratical gynecologic oncology. Williams & Wilkins, Philadelphia, Lippincott 2005; 517–9
   Google Scholar
• Mariani A, Dowdy SC, Keeney GL, Haddock MG, Lesnick TG, Podratz KC. Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol. 2005; 97(3)820–7
   PubMed Web of Science ®Google Scholar
• Carey MS, O'Connell GJ, Johanson CR, Goodyear MD, Murphy KJ, Daya DM, et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 1995; 57(2)138–44
   PubMed Web of Science ®Google Scholar
• Greven KM, Corn BW, Case D, Purser P, Lanciano RM. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?. Int J Radiat Oncol Biol Phys. 1997; 39(2)413–8
   PubMed Web of Science ®Google Scholar
• Zaino RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage – a Gynecologic Oncology Group study. Cancer. 1996; 77(6)1115–21
   PubMed Web of Science ®Google Scholar
• Kwon JS, Carey MS, Cook EF, Qiu F, Paszat L. Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study. Int J Gynecol Cancer. 2007; 17(2)433–40
   PubMed Web of Science ®Google Scholar
• Berchuck A, Anspach C, Evans AC, Soper JT, Rodriguez GC, Dodge R, et al. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol. 1995; 59(1)20–4
   PubMed Web of Science ®Google Scholar
• Boz G, De PA, Innocente R, Talamini R, Scarabelli C, Scozzari G, et al. Postoperative radiotherapy and surgery in stage I endometrial carcinoma: a 10-year experience. Tumori. 1998; 84(1)52–6
   PubMed Web of Science ®Google Scholar
• Calvin DP, Connell PP, Rotmensch J, Waggoner S, Mundt AJ. Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol. 1999; 22(4)338–43
   PubMed Web of Science ®Google Scholar
• Feltmate CM, Duska LR, Chang Y, Flynn CE, Nikrui N, Kiggundu E, et al. Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol Oncol. 1999; 73(3)407–11
   PubMed Web of Science ®Google Scholar
• Martinez A, Schray M, Podratz K, Stanhope R, Malkasian G. Postoperative whole abdomino-pelvic irradiation for patients with high risk endometrial cancer. Int J Radiat Oncol Biol Phys. 1989; 17(2)371–7
   PubMed Web of Science ®Google Scholar
• Mundt AJ, Waggoner S, Yamada D, Rotmensch J, Connell PP. Age as a prognostic factor for recurrence in patients with endometrial carcinoma. Gynecol Oncol. 2000; 79(1)79–85
   PubMed Web of Science ®Google Scholar
• Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23(16)3668–75
   PubMed Web of Science ®Google Scholar
• Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Samuels JR, et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol. 1998; 70(2)165–71
   PubMed Web of Science ®Google Scholar
• Kitchener HK. Fourteenth International Meeting of the European Society Society of Gynecological Oncology (ESGO) Istanbul, Turkey, September 25–29, 2005. Int J Gynecol Oncol. 2005; 15: 51–84
   PubMedGoogle Scholar
• Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004; 92(3)744–51
   PubMed Web of Science ®Google Scholar
• Belinson JL, Lee KR, Badger GJ, Pretorius RG, Jarrell MA. Clinical stage I adenocarcinoma of the endometrium – analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol. 1992; 44(1)17–23
   PubMed Web of Science ®Google Scholar
• Kim YB, Niloff JM. Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy. Obstet Gynecol. 1993; 82(2)175–80
   PubMed Web of Science ®Google Scholar